News

TMCnet10h
ImCheck's Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia
Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML ...
Pharmabiz15h
US FDA grants orphan drug designation to ImCheck’s ICT01 for treatment of acute myeloid leukaemia
Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...